Anatomical Therapeutic Chemical • L01XX32 • bortezomib

A Alimentary tract and metabolism

B Blood and blood forming organs

C Cardiovascular system

D Dermatologicals

G Genito urinary system and sex hormones

H Systemic hormonal preparations, excluding sex hormones and insulins

J Antiinfectives for systemic use

L Antineoplastic and immunomodulating agents

L01 Antineoplastic agents

L01A Alkylating agents

L01B Antimetabolites

L01C Plant alkaloids and other natural products

L01D Cytotoxic antibiotics and related substances

L01E Protein kinase inhibitors

L01F Monoclonal antibodies and antibody drug conjugates

L01X Other antineoplastic agents

L01XA Platinum compounds

L01XB Methylhydrazines

L01XC Monoclonal antibodies

L01XD Sensitizers used in photodynamic/radiation therapy

L01XF Retinoids for cancer treatment

L01XG Proteasome inhibitors

L01XH Histone deacetylase (HDAC) inhibitors

L01XJ Hedgehog pathway inhibitors

L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors

L01XL Antineoplastic cell and gene therapy

L01XM Isocitrate dehydrogenase (IDH) inhibitors

L01XU Other antineoplastic agents (cont.)

L01XX Other antineoplastic agents

L01XX02 asparaginase

L01XX05 hydroxycarbamide

L01XX09 miltefosine

L01XX11 estramustine

L01XX14 tretinoin

L01XX17 topotecan

L01XX19 irinotecan

L01XX22 alitretinoin

L01XX23 mitotane

L01XX24 pegaspargase

L01XX25 bexarotene

L01XX27 arsenic trioxide

L01XX32 bortezomib

L01XX33 celecoxib

L01XX35 anagrelide

L01XX41 eribulin

L01XX42 panobinostat

L01XX43 vismodegib

L01XX44 aflibercept

L01XX45 carfilzomib

L01XX46 olaparib

L01XX50 ixazomib

L01XX52 venetoclax

L01XX73 sotorasib

L01XX74 belzutifan

L01XX75 tebentafusp

L01XX77 adagrasib

L01XX81 nirogacestat

L01XY Combinations of antineoplastic agents

L02 Endocrine therapy

L03 Immunostimulants

L04 Immunosuppressants

M Musculo-skeletal system

N Nervous system

P Antiparasitic products, insecticides and repellents

R Respiratory system

S Sensory organs

V Various